US drugmaker reports promising early results from COVID-19 vaccine test

United States News News

US drugmaker reports promising early results from COVID-19 vaccine test
United States Latest News,United States Headlines
  • 📰 YahooSG
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 71%

The vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people who received it similar to that seen in people convalescing from the virus.

US biotech firm Moderna reported promising early results on Monday from the first clinical tests of an experimental vaccine against the novel coronavirus performed on a small number of volunteers.

President Donald Trump welcomed the news saying"it's incredible what they can do and I've seen results. "We could not be happier about these interim data," Bancel said of the Phase 1 test, the first of three in the development of a vaccine. The Phase 2 trial, with 600 subjects, has already received the green light from the US Food and Drug Administration and Moderna said they should begin this quarter.

"The lower the dose, the more people we expect to be able to protect," said Moderna president Stephen Hoge.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooSG /  🏆 3. in SG

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China–US blame game hampers Covid-19 responseChina–US blame game hampers Covid-19 responseThe world is entangled in the blame game between China and the United States as it confronts the largest public health threat in a century.
Read more »

US: Stocks surge on Covid-19 vaccine progress, Dow ends +3.9%US: Stocks surge on Covid-19 vaccine progress, Dow ends +3.9%[NEW YORK] Wall Street stocks rocketed higher on Monday following positive news on the first clinical tests of a coronavirus vaccine, lifting shares of airlines, hotels and other beaten-down sectors. Read more at The Business Times.
Read more »

COVID-19: Macron, Merkel agree US$545b recovery plan for EuropeCOVID-19: Macron, Merkel agree US$545b recovery plan for EuropeBERLIN: France and Germany proposed on Monday (May 18) a 500-billion-euro (US$545-billion) fund to finance the recovery of the European Union's ...
Read more »

COVID-19: France, Germany chart US$545b fund as European lockdown easesCOVID-19: France, Germany chart US$545b fund as European lockdown easesBERLIN: France and Germany on Monday (May 18) laid out plans for a 500-billion-euro (US$545 billion) European fund backed by joint EU borrowing to ...
Read more »

US says WHO 'failure' on Covid-19 'cost many lives'US says WHO 'failure' on Covid-19 'cost many lives'GENEVA (AFP) - The United States on Monday (May 18) slammed the World Health Organization's 'failure' to obtain and provide vital information on Covid-19 that could have reined in the pandemic and saved many lives.. Read more at straitstimes.com.
Read more »

US firm announces 'positive interim' phase 1 results for COVID-19 vaccineUS firm announces 'positive interim' phase 1 results for COVID-19 vaccineWASHINGTON: US biotech firm Moderna reported 'positive interim' results on Monday (May 18) in the first clinical tests of its vaccine against the ...
Read more »



Render Time: 2025-03-10 22:06:10